Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
Clinical trial NCT03215810 · COMPLETED
Trial details
- NCT number
- NCT03215810
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-11
- Primary completion
- 2021-02-13
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.